Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The components of basic and diluted net income and net loss per common share were as follows for the periods stated:

	For the Year Ended December 31,
(In thousands, except for share and per share amounts)	2023		2022		2021
Numerator:
Net income (loss)	$	15,666	$	21,856	$	(22,180)
Denominator:
Basic weighted average common shares outstanding	19,953,747		19,672,423		19,404,477
Diluted weighted average common shares outstanding	20,343,912		19,991,202		19,404,477
Basic net income (loss) per common share	$	0.79	$	1.11	$	(1.14)
Diluted net income (loss) per common share	$	0.77	$	1.09	$	(1.14)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the years ended December 31, 2023, 2022 and 2021, the following securities were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:

	For the Year Ended December 31,
	2023	2022	2021
Restricted stock units	—	—	371,194

Schedule of Activities Under Equity Plan

The following table summarizes the activities under the Equity Plan from January 1, 2021 through December 31, 2023:

	Activity
Total equity securities available at January 1, 2021	1,699,314
Less: stock issued in lieu of cash compensation	(169,944)
Less: RSU and restricted stock awarded to eligible employees, net of forfeitures	(539,241)
Total equity securities available at December 31, 2021	990,129
Less: RSU, DSU and restricted stock awarded to eligible employees, net of forfeitures	(307,077)
Total equity securities available at December 31, 2022	683,052
Plus: Additional shares available for issuance under the Equity Plan	1,000,000
Less: RSU, DSU and restricted stock awarded to eligible employees, net of forfeitures	(407,348)
Total equity securities available at December 31, 2023	1,275,704

Schedule of Additional Awards Under 2011 LTIP

The following table details activities with respect to outstanding RSUs, DSUs, and restricted stock under the Equity Plan for the year ended December 31, 2023:

	Shares	Weighted-Average Grant Date Fair Value per Share
Unvested at January 1, 2023	1,015,749	$	10.25
Granted	471,272	8.46
Vested	(387,829)	11.09
Forfeited	(63,924)	10.28
Unvested at December 31, 2023	1,035,268	$	9.12

Schedule of Activities Under Equity Plan From Inception

The following table summarizes the activities under the ESPP from January 1, 2021, through December 31, 2023:

	Activity
Total ESPP equity securities available at January 1, 2021	149,199
Less: common stock purchased by eligible employees	(16,015)
Total ESPP equity securities available at January 1, 2022	133,184
Less: common stock purchased by eligible employees	—
Total ESPP equity securities available at January 1, 2023	133,184
Less: common stock purchased by eligible employees	(23,422)
Total ESPP equity securities available at December 31, 2023	109,762

Summary of Stock Based Compensation Expense

The following table reflects stock-based compensation expense for the periods stated:

	For the Year Ended December 31,
(Dollars in thousands)	2023		2022		2021
Performance-based RSUs	$	1,809	$	1,559	$	1,608
Time-based RSUs and restricted stock	2,192		2,260		3,754
Equity in lieu of salary	—		—		1,845
ESPP	62		8		32
Total stock-based compensation	$	4,063	$	3,827	$	7,239